Atomoxetine affects transcription/translation of the NMDA receptor and the norepinephrine transporter in the rat brain – an in vivo study

Attention-deficit/hyperactivity disorder (ADHD) is the most frequently diagnosed neurodevelopmental disorder. The norepinephrine transporter (NET) inhibitor atomoxetine, the first nonstimulant drug licensed for ADHD treatment, also acts as an N-methyl-D-aspartate receptor (NMDAR) antagonist. The com...

Descripción completa

Detalles Bibliográficos
Autores principales: Udvardi, Patrick T, Föhr, Karl J, Henes, Carolin, Liebau, Stefan, Dreyhaupt, Jens, Boeckers, Tobias M, Ludolph, Andrea G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857115/
https://www.ncbi.nlm.nih.gov/pubmed/24348020
http://dx.doi.org/10.2147/DDDT.S50448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857115/
https://www.ncbi.nlm.nih.gov/pubmed/24348020
http://dx.doi.org/10.2147/DDDT.S50448

Ejemplares similares